Aeterna Wealth
Sectoral/Thematic · Regular plan · Growth

Baroda BNP Paribas Health and Wellness Fund (Regular)

Baroda BNP Paribas Mutual Fund · benchmark Nifty 500 TRI · 1.3 years old · AMFI code 153602

–
Track-record rating

Not rated yet: a rating needs at least 3 years of history (1 year for index funds).

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months11.9%2.5%+9.4%12 / 17
1 year10.9%-1.0%+12.0%13 / 16
3 years (a year)––––
5 years (a year)––––

Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Portfolio

Sun Pharmaceutical Industries Limited8.6%
Torrent Pharmaceuticals Limited7.9%
Divi's Laboratories Limited7.8%
IPCA Laboratories Limited6.1%
Laurus Labs Limited6.1%
Lupin Limited5.8%
Apollo Hospitals Enterprise Limited5.3%
Fortis Healthcare Limited4.0%
Dr. Lal Path Labs Limited3.5%
Mankind Pharma Limited3.3%

Top 10 holdings, September 2026 portfolio.

Common questions

What is the NAV of Baroda BNP Paribas Health and Wellness Fund (Regular plan)?

₹10.78 on 5 Nov 2026 (Growth option).

What is the expense ratio of Baroda BNP Paribas Health and Wellness Fund (Regular)?

2.70% a year; the Direct plan's is 1.55%.

What does Baroda BNP Paribas Health and Wellness Fund invest in?

Its largest holdings are Sun Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Divi's Laboratories Limited, with 33 stocks in all (September 2026 portfolio).

Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from Baroda BNP Paribas Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.